News
SLDB
9.08
+0.17%
0.02
Analysts Offer Insights on Healthcare Companies: Clinigence Holdings (NUTX), Vera Therapeutics (VERA) and Solid Biosciences (SLDB)
TipRanks · 2d ago
Airsculpt Technologies, Barrick Mining And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
Benzinga · 3d ago
Solid Biosciences: Advancing Gene Therapy Pipeline, Strong Cash Runway Support Buy Rating with Unchanged $14 Price Target
TipRanks · 3d ago
Weekly Report: what happened at SLDB last week (0803-0807)?
Weekly Report · 3d ago
At a glance: stocks gapping down premarket
Seeking Alpha · 6d ago
Analysts Offer Insights on Healthcare Companies: CVRx (CVRX) and Solid Biosciences (SLDB)
TipRanks · 6d ago
Analysts Offer Insights on Healthcare Companies: Xenon (XENE) and Solid Biosciences (SLDB)
TipRanks · 6d ago
Solid Biosciences Q2 EPS $(0.38) Beats $(0.46) Estimate
Benzinga · 08/06 22:26
Solid Biosciences Updates Shelf for $200 Million Offering
TipRanks · 08/06 22:20
Solid Biosciences reports Q2 EPS (38c), consensus (47c)
TipRanks · 08/06 21:40
Solid Biosciences Files Prospectus To Offer Up To $200M In Common Stock
Benzinga · 08/06 21:29
Solid Biosciences GAAP EPS of -$0.38 beats by $0.08
Seeking Alpha · 08/06 21:20
Solid Biosciences Files Prospectus For Mixed Shelf Offering; Size Not Disclosed
Benzinga · 08/06 21:10
Solid Biosciences files automatic mixed securities shelf
TipRanks · 08/06 21:07
Press Release: Solid Biosciences Reports Second -2-
Dow Jones · 08/06 20:08
Weekly Report: what happened at SLDB last week (0727-0731)?
Weekly Report · 08/03 09:07
Weekly Report: what happened at SLDB last week (0720-0724)?
Weekly Report · 07/27 09:07
Weekly Report: what happened at SLDB last week (0713-0717)?
Weekly Report · 07/20 09:07
Weekly Report: what happened at SLDB last week (0706-0710)?
Weekly Report · 07/13 09:07
How Investors May Respond To Solid Biosciences (SLDB) Joining Multiple Russell Growth Indices
Simply Wall St · 07/10 22:36
More
Webull provides a variety of real-time SLDB stock news. You can receive the latest news about Solid Bioscience through multiple platforms. This information may help you make smarter investment decisions.
About SLDB
Solid Biosciences Inc. is a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases. The Company is focused on advancing a portfolio of gene therapy candidates including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy and additional assets for the treatment of genetic cardiac and neuromuscular disease. It also has two cardiac pipeline gene transfer programs, SGT-401 for BAG3-mediated DCM, which is in early preclinical development, and SGT-701 for RBM20 DCM, which is in the discovery stage. In addition to its gene transfer candidates, the Company has development programs focusing on platform technologies, including capsid libraries and dual gene expression, a technology that allows it to package multiple transgenes into one capsid.